Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust

 
back
6 Endocrine system


06-06-02 Bisphosphonates and other drugs affecting bone metabolism

Burosumab Crysvita®
Formulary
  • 10mg/1ml, 20mg/1ml & 30mg/1ml solution for injection
  • Approved for treating X-linked hypophosphataemia in children and young people in accordance with NICE
  • Link  NICE HST 8: Burosumab for treating X-linked hypophosphataemia in children and young people
     

    Red View adult BNF  View SPC online